We had the pleasure to read the paper published online by Krouse et al.in August 2023 in the Lancet Gastroenterology and Hepatology(1).The study labeled as S1316 was a prospective pragmatic comparative effectiveness t...We had the pleasure to read the paper published online by Krouse et al.in August 2023 in the Lancet Gastroenterology and Hepatology(1).The study labeled as S1316 was a prospective pragmatic comparative effectiveness trial evaluating the surgical versus non-surgical management for patients with malignant small intestinal bowel obstruction(MIO)and having an intra-abdominal or retroperitoneal primary cancer and were aged 18 years or older with a Zubrod performance status 0-2 within 1 week before admission;had a surgical indication;and treatment equipoise.The patients were divided in two pathways.Those who accepted the randomization were randomly assigned to surgical and non-surgical treatment groups.Those who declined consent for random assignment were offered a prospective observational patient choice pathway where the patients with their caring team decide upon the treatment option.展开更多
In July 2021 a new governmental cancer center,the Sultan Qaboos Comprehensive Cancer Care and Research Centre(SQCCCRC)(Figure 1)open its doors to provide excellent,evidenced-based patient-centered care for cancer pati...In July 2021 a new governmental cancer center,the Sultan Qaboos Comprehensive Cancer Care and Research Centre(SQCCCRC)(Figure 1)open its doors to provide excellent,evidenced-based patient-centered care for cancer patients in the Sultanate of Oman.SQCCCRC is dedicated to treat cancer patients while building an environment to continuously advance clinical and scientific innovation in the treatment of Cancer.展开更多
文摘We had the pleasure to read the paper published online by Krouse et al.in August 2023 in the Lancet Gastroenterology and Hepatology(1).The study labeled as S1316 was a prospective pragmatic comparative effectiveness trial evaluating the surgical versus non-surgical management for patients with malignant small intestinal bowel obstruction(MIO)and having an intra-abdominal or retroperitoneal primary cancer and were aged 18 years or older with a Zubrod performance status 0-2 within 1 week before admission;had a surgical indication;and treatment equipoise.The patients were divided in two pathways.Those who accepted the randomization were randomly assigned to surgical and non-surgical treatment groups.Those who declined consent for random assignment were offered a prospective observational patient choice pathway where the patients with their caring team decide upon the treatment option.
文摘In July 2021 a new governmental cancer center,the Sultan Qaboos Comprehensive Cancer Care and Research Centre(SQCCCRC)(Figure 1)open its doors to provide excellent,evidenced-based patient-centered care for cancer patients in the Sultanate of Oman.SQCCCRC is dedicated to treat cancer patients while building an environment to continuously advance clinical and scientific innovation in the treatment of Cancer.
